ATE258793T1 - 5-ht2 agonisten als mittel zur kontrolle des augeninnendrucks und zur behandlung von glaukom - Google Patents

5-ht2 agonisten als mittel zur kontrolle des augeninnendrucks und zur behandlung von glaukom

Info

Publication number
ATE258793T1
ATE258793T1 AT00978627T AT00978627T ATE258793T1 AT E258793 T1 ATE258793 T1 AT E258793T1 AT 00978627 T AT00978627 T AT 00978627T AT 00978627 T AT00978627 T AT 00978627T AT E258793 T1 ATE258793 T1 AT E258793T1
Authority
AT
Austria
Prior art keywords
agonists
agent
treating glaucoma
eye pressure
controlling eye
Prior art date
Application number
AT00978627T
Other languages
English (en)
Inventor
Jesse A May
Anura P Dantanarayana
Original Assignee
Alcon Inc
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc, Yamanouchi Pharma Co Ltd filed Critical Alcon Inc
Application granted granted Critical
Publication of ATE258793T1 publication Critical patent/ATE258793T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00978627T 2000-03-17 2000-11-14 5-ht2 agonisten als mittel zur kontrolle des augeninnendrucks und zur behandlung von glaukom ATE258793T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19028800P 2000-03-17 2000-03-17
PCT/US2000/031246 WO2001070207A2 (en) 2000-03-17 2000-11-14 5ht2 agonists for controlling iop and treating glaucoma

Publications (1)

Publication Number Publication Date
ATE258793T1 true ATE258793T1 (de) 2004-02-15

Family

ID=22700724

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00978627T ATE258793T1 (de) 2000-03-17 2000-11-14 5-ht2 agonisten als mittel zur kontrolle des augeninnendrucks und zur behandlung von glaukom

Country Status (19)

Country Link
EP (1) EP1267847B1 (de)
JP (1) JP2003527415A (de)
KR (1) KR100499903B1 (de)
CN (1) CN1231214C (de)
AR (1) AR026707A1 (de)
AT (1) ATE258793T1 (de)
AU (2) AU1607101A (de)
BR (1) BR0017158A (de)
CA (1) CA2401969A1 (de)
DE (1) DE60008151T2 (de)
DK (1) DK1267847T3 (de)
ES (1) ES2210018T3 (de)
MX (1) MXPA02008548A (de)
PL (1) PL358296A1 (de)
PT (1) PT1267847E (de)
TR (1) TR200400424T4 (de)
TW (1) TW546139B (de)
WO (1) WO2001070207A2 (de)
ZA (1) ZA200206852B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
TW593302B (en) 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
BR0316775A (pt) 2002-12-13 2005-11-01 Alcon Inc Novos análogos de benzopirano e seu uso para o tratamento de glaucoma
US7476687B2 (en) * 2003-11-26 2009-01-13 Alcon, Inc. Substituted furo[2,3-g]indazoles for the treatment of glaucoma
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
AR046890A1 (es) 2003-12-15 2005-12-28 Alcon Inc [1,4] oxazino [2,3-g] indazoles sustituidos para el tratamiento del glaucoma.
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
JP5173190B2 (ja) 2004-08-25 2013-03-27 武田薬品工業株式会社 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
WO2006062839A1 (en) 2004-12-08 2006-06-15 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
JP5528699B2 (ja) 2006-05-16 2014-06-25 武田薬品工業株式会社 縮合複素環化合物およびその用途
JP5520051B2 (ja) 2007-11-15 2014-06-11 武田薬品工業株式会社 縮合ピリジン誘導体およびその用途
WO2011071136A1 (ja) 2009-12-11 2011-06-16 アステラス製薬株式会社 線維筋痛症治療剤
WO2019131902A1 (ja) 2017-12-27 2019-07-04 武田薬品工業株式会社 腹圧性尿失禁および便失禁の治療薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5343298A (en) * 1997-01-13 1998-08-03 Yamanouchi Pharmaceutical Co., Ltd. 5-ht2c receptor agonists and aminoalkylindazole derivatives
AU2042301A (en) * 1999-12-03 2001-06-12 Alcon Universal Limited 1-aminoalkyl-1H-indoles for treating glaucoma

Also Published As

Publication number Publication date
ES2210018T3 (es) 2004-07-01
PL358296A1 (en) 2004-08-09
TR200400424T4 (tr) 2004-03-22
MXPA02008548A (es) 2004-08-23
DE60008151T2 (de) 2004-07-08
WO2001070207A3 (en) 2002-05-10
DE60008151D1 (de) 2004-03-11
CN1231214C (zh) 2005-12-14
AU1607101A (en) 2001-10-03
ZA200206852B (en) 2003-08-27
JP2003527415A (ja) 2003-09-16
PT1267847E (pt) 2004-05-31
AU2001216071B2 (en) 2004-12-02
TW546139B (en) 2003-08-11
EP1267847B1 (de) 2004-02-04
CN1450897A (zh) 2003-10-22
BR0017158A (pt) 2003-06-03
WO2001070207A2 (en) 2001-09-27
CA2401969A1 (en) 2001-09-27
KR20030095185A (ko) 2003-12-18
KR100499903B1 (ko) 2005-07-07
EP1267847A2 (de) 2003-01-02
AR026707A1 (es) 2003-02-26
DK1267847T3 (da) 2004-03-08
HK1050143A1 (en) 2003-06-13

Similar Documents

Publication Publication Date Title
DE60022692D1 (de) (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
ATE257385T1 (de) Zusammensetzungen und verfahren zur behandlung des erhöhten augenindruckes
DE60108080D1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
DE60101265D1 (de) Behandlung von augenschmerzen
DE60008151D1 (de) 5-ht2 agonisten als mittel zur kontrolle des augeninnendrucks und zur behandlung von glaukom
ATE319439T1 (de) Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd
DE60021908D1 (de) Hydroxyeicosatetraenoatsalze, zusammensetzungen und verfahren zur verwendung zur behandlung des trockenen auges
CY1106409T1 (el) Παραγωγα κινολινης
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
ATE375141T1 (de) Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer
DE69935853D1 (de) Anwendung von alfa1beta1 integrinrezeptorinhibitoren und tgf-beta1-inhibitoren zur behandlung von nierenkrankheiten
ATE415163T1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE60218153D1 (de) Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
EP1441761A4 (de) Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren
WO2004091436A3 (en) Methods and compositions for treating ocular disease
ATE443060T1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
DE60231246D1 (de) Superoxiddismutas-mimetika zur behandlung von augenerkrankungen
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
DE60138385D1 (de) Heilmittel zur behandlung von erkrankungen des sehnervs
DE60135972D1 (de) Orhthalmologische zusammenstellungen zur behandlung von ocularer hypertension
BRPI0607684A2 (pt) composição farmacêutica, método para prevenir ou tratar distúrbios de depressão ou ansiedade, e, uso de (s)-n-[2-(1,6,7,8-tetraidro-2h-indeno[5,4-b]furan-8-il)-eti l]-propionamida
DE60109594D1 (de) R-eliprodil zur behandlung von glaucoma
MXPA04010816A (es) Acidos aminoalcanfosfonicos sustituidos para el tratamiento de dolor neuropatico, trastornos afectivos y de la atencion, esquizofrenia, tinitus, miopia y otros trastornos oculares.
ATE343387T1 (de) S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
DE60222143D1 (de) Verwendung von nicht feminisierenden östrogenen als retinoprotektive mittel zur behandlung von glaukom

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1267847

Country of ref document: EP

REN Ceased due to non-payment of the annual fee